News - Events

This meeting will feature discussions about new syringe and injectable drug device technologies with an update on product development and the regulatory landscape. The conference will also address issues relating to the implementation of the new technologies. Experts from the industry will also discuss best practice, enabling delegates to learn from their experiences.  

The pharmaceutical microbiology industry has seen many changes since the start of the 21st century. These include new methods for discovery, updated regulation and a greater understanding of the role of the microbiome in human health. This meeting will bring together industry experts and others to discuss and analyse the latest advances and challenges for pharmaceutical microbiology. 

Many scientific, methodological and regulatory challenges in the research and development of treatments for different diseases have been successfully overcome in the past years.

However, in order to reach the ultimate ethical objective of ensuring patient centricity in treatment development, changes must be envisaged in our healthcare environment. During this conference we will hear from ethics, physician, patient, industry and government experts and discuss with the audience about new process proposals to achieve such an integration of research in healthcare.   

Cell culture is an important tool for research and development in the life science industry. In recent years, three-dimensional cell culture, where cells can be observed growing and interacting with their surroundings, has attracted interest in the pharmaceutical industry.

This conference will bring together industry experts from leading RNA companies to discuss the challenges of clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies. The event will also give an overview of projects for RNA-based drugs that involve the modulation of gene and protein expression as well as genome editing.

Returning in 2019 after a 2018 debut, Phar-East will once again bring together experts from biopharmaceutical companies, regulators, payers and technology innovators to discuss growth opportunities in Asia and the specific requirements for developing and launching drugs in this regional market. The conference will feature sessions on immunotherapy, regulatory affairs and pricing and reimbursement.